Rheumatology: 5. Diagnosis and management of inflammatory polyarthritis

CMAJ. Canadian Medical Association Journal

Volumn 162, Issue 13, 2000, Pages 1833-1838

  Klinkhoff, Alice ^a,b,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ARTHRITIS RESEARCH CENTRE OF CANADA   (Canada)

^c NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; MINOCYCLINE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; SALAZOSULFAPYRIDINE; STEROID;

CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; GOUT; HUMAN; OSTEOARTHRITIS; POLYARTHRITIS; PSORIATIC ARTHRITIS; REVIEW; RHEUMATOID ARTHRITIS; SPONDYLOARTHROPATHY; SYNOVITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0034720742     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Kolstoe J, Messner RP. Lyme disease: musculoskeletal manifestations. Rheum Dis Clin North Am 1989; 15:649-56.
2. Sergent JS. Approach to the patient with pain in more than one joint. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, editors. Textbook of rheumatology. 5th ed. Philadelphia: WB Saunders; 1997. p. 381-7.
3. Arnett FC. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
4. Tighe H, Carson D. Rheumatoid factors. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, editors. Texttoot of rheumatology. 5th ed. Philadelphia: WB Saunders; 1997. p. 241-9.
5. Shojania K. Rheumatology: 2. What laboratory tests are needed? CMAJ 2000;162(8):1157-63. Available: www.cma.ca/cmaj/vol-162/issue-8/l 157.htm
6. Luukainen R, Kajender A, Isomaki II. Effect of gold on the progression of erosions in rheumatoid arthritis: better results with early treatment. ScundJ Rtcamatol l977;6:\S9-92.
7. Tsakonas E, Fitzgerald AA, Fitzcharles MA, Cividino A, Thorne JC, M'Seffar A, et al. Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3-year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study.7Ai;OTo/2000;27:623-9.
8. HERA Study Group. A randomized trial of hydroxychloroquine in early rheumatoid arthritis: the HERA Study. AmJMed 1995;98:156-68.
9. O'Dell JR, Haire CE, Palmer W, Drymalski W, Wees S, Blakely K, et al. Treatment of early rheumatoid arthritis with minocycline or placebo: results of a randomized double-blind placebo-controlled trial. Arthritis Rheum 1997; 40:842-8.
10. Rau R, Herborn G, Menninger H, Blechschmidt J. Comparison of intramuscular methotrexate and gold sodium thiomalate in the treatment of early erosive rheumatoid arthritis: 12 month data of a double-blind parallel study of 174 patients. BrJRbeumatol 1997;36:345-52.
11. Gladman DD. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, editors. Textbook of rheumatology. 5th ed. Philadelphia: WB Saunders; 1997. p. 999-1005.
12. Ziminsld CM. In: Schur PH, editor. Ahisailoskeletal manifestations in the clinical management of systemic lupus erytbematosus. 2nd ed. Philadelphia: LipincottRaven; 1996. p. 47-65.
13. Rynes R. Antimalarial drugs. In: Kelley \\TM, Harris ED, Ruddy S, Sledge CB, editors. Textlook of rheumatology. 5th ed. Philadelphia: WB Saunders; 1997. p. 747-58.